A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
February 21, 2019
Premier Inc. Projects 3.8 Percent Price Inflation for Pharmaceuticals
CHARLOTTE, N.C. —Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today released its inflation estimates for contracted and non-contracted pharmaceutical pricing for fiscal...
February 05, 2019
Baxter and Premier’s ProvideGx™ Subsidiary Collaborate to Address Drug Shortages
Strategic partnership brings a new source of supply to providers, innovating to alleviate the two-year shortage of metoprolol injection.
February 04, 2019
Blood-Pressure Medicine Will Be First Product for New Generic Drug Venture
The Wall Street Journal | ProvideGx, a new generic-drug venture, will begin supplying metoprolol in the middle of this month.
February 01, 2019
Premier Statement on the Patient Affordability Value and Efficiency Act
By Blair Childs, Senior Vice President of Public Affairs, Premier The Premier healthcare alliance applauds Senators Cassidy and Warner for proposing legislation to remove...
January 29, 2019
Premier Urges Congressional Committees to Adopt Sustainable Solutions to Address Rising Drug Prices
Premier submitted statements for the record for today’s drug pricing hearings in the Senate Finance Committee and House Committee on Oversight and Reform. As...
January 23, 2019
Premier Provides Input on FDA Proposed Framework for Regulating Drug-Use-Related Software
Premier submitted comments to the FDA in response to its proposed framework for regulating prescription drug-use-related software applications. Premier cautioned the FDA to ensure...
January 15, 2019
Statement on AHA/FAH/ASHP Study on Drug Shortages
By Blair Childs, Senior Vice President of Public Affairs, Premier As the national leader in combating drug price increases and drug shortages, we applaud...
January 15, 2019
What We’re Watching: January 15, 2019
NO MORE SHORTAGES Even with the shutdown, FDA Commissioner Gottlieb has made it clear that funds are available to ensure no slowdown in the...
January 14, 2019
Premier Inc. Announces Expanded Effort to Supply Shortage Generic Drugs
CHARLOTTE, N.C. (January 14, 2019) — Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced a company it has established to help...
January 11, 2019
Premier Offers Solutions to FDA to Eliminate Drug Shortages
Premier provided input to the Food and Drug Administration on the underlying systemic causes of drug shortages and recommendations for actions to prevent or...
January 03, 2019
Opioid Overdoses Costing U.S. Hospitals an Estimated $11 Billion Annually
CHARLOTTE, N.C. -– A recent Premier Inc. (NASDAQ: PINC) analysis found that total care for patients who experienced an opioid overdose resulted in $1.9...
December 12, 2018
Advisor Live® Webinar: Medicare Part B International Pricing Index (IPI)
In late October, CMS announced a new “International Pricing Index” payment model to reduce the cost of prescription drugs. Premier previously put together a...
December 04, 2018
What We’re Watching: December 4, 2018
SHORTAGE PROBS A panel of industry experts met last week to discuss the root causes of drug shortages and solutions to the problem during...
November 29, 2018
Industry Experts, Clinicians Seek Solutions to Drug Shortages
MedPage Today | Blair Childs discusses four common problems that lead to drug shortages.
November 07, 2018
Susan DeVore Discusses the Fate of Healthcare With a Divided Congress
Supply Chain
| Quality Improvement
| Pharmacy
| Population Health
| Finance & Operations
| Data & Analytics
| Applied Sciences
| Advocacy
|
Premier in the News
Cheddar TV | Susan DeVore joined Cheddar TV to discuss the road ahead for healthcare, including implications for healthcare providers.
October 15, 2018
What We’re Watching: October 15, 2018
HURRICANE MICHAEL The U.S. Department of Health and Human Services Secretary declared a Public Health Emergency in Florida and Georgia in the wake of...
October 02, 2018
Premier Statement on FDA Action to Address the Use of Citizen Petitions to Delay Market Competition of Generics and Biosimilars
Members of Premier applaud the Food and Drug Administration (FDA) for releasing revised draft guidance on the use of citizen petitions to delay the...
September 26, 2018
Premier Statement on Congressional Action on Pharmacy Gag Clause Legislation (S. 2553 and S. 2554)
The Premier healthcare alliance and its members applaud the House of Representatives for advancing legislation that will help lower the cost of prescription drugs...
September 04, 2018
Premier Testifies During FDA Biological Products Marketplace Hearing
Premier testified during the Food and Drug Administration’s (FDA’s) public hearing to facilitate competition and innovation in the biological products marketplace on Sept. 4, 2018...
July 26, 2018
Biosimilars Competition Act Letter
Premier Inc. comment letter to Congressman Sarbanes and Congressman Johnson to support the Biosimilars Competition Act of 2018.
June 28, 2018
Ahead of the Curve is the Only Safe Place to Be
Supply Chain
| Quality Improvement
| Pharmacy
| Population Health
| Finance & Operations
| Data & Analytics
| Applied Sciences
|
Blog
Premier COO Mike Alkire kicked off our 2018 Breakthroughs Conference and Exhibition last month discussing changes in the healthcare market – from technological advances to...
